Xiangying Kong

Dr. Xiangying Kong


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
HCHuantian Cui
Huantian Cui
NWNing Wang
Ning Wang
HLHanzhou Li
Hanzhou Li
YBYuhong Bian
Yuhong Bian
WWWeibo Wen
Weibo Wen
Fudi WangFudi Wang
Fudi Wang
The changes in T regulatory cell (Treg) and T helper cell (Th) 17 ratios holds paramount importance in ensuring internal homeostasis and disease progression. Recently, novel subsets of Treg and Th17, namely IL-17-producing Treg and IL-10-producing Th17 have been identified. IL-17-producing Treg and IL-10-producing Th17 are widely considered as the intermediates during Treg/Th17 transformation. These “bi-functional” cells exhibit plasticity and have been demonstrated with important roles in multiple physiological functions and disease processes. Yin and Yang represent opposing aspects of phenomena according to the ancient Chinese philosophy “Yin-Yang” theory. Furthermore, Yin can transform into Yang, and vice versa, under specific conditions. This theory has been widely used to describe the contrasting functions of immune cells and molecules. Therefore, immune-activating populations (Th17, M1 macrophage, etc.) and immune overreaction (inflammation, autoimmunity) can be considered Yang, while immunosuppressive populations (Treg, M2 macrophage, etc.) and immunosuppression (tumor, immunodeficiency) can be considered Yin. However, another important connotation of “Yin-Yang” theory, the conversion between Yin and Yang, has been rarely documented in immune studies. The discovery of IL-17-producing Treg and IL-10-producing Th17 enriches the meaning of “Yin-Yang” theory and further promotes the relationship between ancient “Yin-Yang” theory and modern immunology. Besides, illustrating the functions of IL-17-producing Treg and IL-10-producing Th17 and mechanisms governing their differentiation provides valuable insights into the mechanisms underlying the dynamically changing statement of immune statement in health and diseases.

1 May 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XSXiaohui Su
Xiaohui Su
WGWanyi Guo
Wanyi Guo
BYBei Yuan
Bei Yuan
DWDong Wang
Dong Wang
LLLiling Liu
Liling Liu
NLNa Lin
Na Lin
Accumulating studies have indicated that reactive oxygen species (ROS) may be implicated into the destructive pathological events of rheumatoid arthritis (RA). As an effective antioxidant, artesunate (ARS) was reported to exert antiarthritic effects. However, whether ARS attenuates the bone erosion during RA progression by regulating ROS production remains to be defined. To address this problem, the inhibitive effects of ARS on osteoclastogenesis were observed in vitro. Mechanically, ARS significantly inhibited the NFATc1 signaling accompanied by markedly suppressing ROS production, which was abnormally enhanced during the pathological process of bone erosion. In addition, ARS may function as a potent ROS scavenger and significantly elevate the expression of HO-1 and NQO1 by activating Nrf2. Moreover, p62 accumulation induced by ARS was responsible for the activation of Nrf2, while the knockdown of p62 in osteoclast precursor cells diminished the suppressive effect of ARS on ROS production during osteoclastogenesis. Consistently, we also demonstrated that ARS effectively suppressed ROS production, leading to the inhibition of arthritic bone destruction by activating antioxidant enzyme and Nrf2/p62 signaling in the knee and ankle tissues of CIA rats. Collectively, our data offer the convincing evidence that ARS may inhibit osteoclastogenesis and ameliorate arthritic bone erosion through suppressing the generation of ROS via activating the p62/Nrf2 signaling.

28 November 2015 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
XKXiangying Kong
Xiangying Kong
MZMicun Zhong
Micun Zhong
XSXiaohui Su
Xiaohui Su
QQQingxia Qin
Qingxia Qin
HSHongchang Su
Hongchang Su
NLNa Lin
Na Lin

10 May 2024 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
MQMingzhu Qi
Mingzhu Qi
XSXiaohui Su
Xiaohui Su
ZLZhuohang Li
Zhuohang Li
HHHelan Huang
Helan Huang
JWJingbo Wang
Jingbo Wang
XKXiangying Kong
Xiangying Kong

1 January 2017 in International Journal of Biological Sciences
Verified
Journal Article
Open access
CLCuiling Liu
Cuiling Liu
HSHongchang Su
Hongchang Su
HWHongye Wan
Hongye Wan
QQQingxia Qin
Qingxia Qin
XWXuan Wu
Xuan Wu
NLNa Lin
Na Lin
Transient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel gated by noxious heat, playing major roles in thermoregulation. Forsythoside A (FT-A) is the most abundant phenylethanoid glycosides in Fructus Forsythiae, which has been prescribed as a medicinal herb for treating fever in China for a long history. However, how FT-A affects pyrexia and what is the underlying molecular mechanism remain largely unknown. Here we found that FT-A exerted apparent antipyretic effect through decreasing the levels of prostaglandin E2 (PGE2) and interleukin 8 (IL-8) in a dose-dependent fashion on the yeast induced pyrexia mice. Interestingly, FT-A significantly downregulated TRPV1 expression in the hypothalamus and dorsal root ganglion (DRG) of the yeast induced pyrexia mice. Moreover, FT-A inhibited IL-8 and PGE2 secretions, and calcium influx in the HEK 293T-TRPV1 cells after stimulated with capsaicin, the specific TRPV1 agonist. Further investigation of the molecular mechanisms revealed that FT-A treatment rapidly inhibited phosphorylation of extracellular signal-regulated kinase (ERK), Jun N-terminal kinase (JNK) and p38 in both yeast induced pyrexia mice and HEK 293T-TRPV1 cells. These results suggest that FT-A may serve as a potential antipyretic agent and the therapeutic action of Fructus Forsythiae on pyretic related disease is, in part, due to the FT-A activities.

10 October 2024 in Phytomedicine
Verified
Journal Article
Closed access
MQMingzhu Qi
Mingzhu Qi
HHHelan Huang
Helan Huang
ZLZhuohang Li
Zhuohang Li
JQJianye Quan
Jianye Quan
JWJingbo Wang
Jingbo Wang
XKXiangying Kong
Xiangying Kong